Annals of Oncology Advance Access originally published online on June 4, 2008
Annals of Oncology 2008 19(7):1216-1217; doi:10.1093/annonc/mdn384
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© The Author 2008. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please email: journals.permissions@oxfordjournals.org
editorials |
Cancer survivorship: a challenge for the European oncologists
1 Division of Medical A, National Cancer Institute, Aviano
2 Medical Office, National Cancer Institute, Aviano, Italy
* E-mail: csimonelli@cro.it; omaoffice@cro.it
| The first 10% of the full text of this article appears below. |
Cancer survival is significantly increased all over Europe [1, 2], and the cancer prevalence in Europe is estimated to be 2.6% [3]. In the United States,
10.5 million subjects are cancer survivors [4]. This estimate is on the basis of the definition that anyone who has been diagnosed with cancer, from the time of diagnosis to the rest of her/his life, is a cancer survivor. However, the research into survivors of adult cancer is in its infancy and little has been done especially outside the United States [5].
Many are the clinical and research implications in cancer survivorship that need to be addressed by the European oncologists.
First,